Biocidal Product in the EU will eventually require product authorisation under the Biocidal Product Regulation (BPR, Regulation (EU) 528/2012) before they can be placed on the market. This is a two-step process beginning with active substance approval. An active substance must be granted an approval decision for the relevant product-type(s) prior to obtaining BPR biocidal product authorisation.
This webinar will provide an overview of the BPR and its main principles, and guide you through the phases required to successfully submit a product authorisation dossier and achieve compliance within the set regulatory deadlines.
The session will cover:
- Biocidal product definition
- Evaluation process under BPR
- Biocidal product authorisation requirements and steps to a successful product authorisation
- Take-home messages
Who should attend:
- Companies placing or making available biocidal products on the market
Presenter: Dr Rosalinda Gioia, Principal: Scientific Services
Date/Time: Tuesday 12 February 2019, 15:00 – 15:30 GMT